For how we live.
A Manaus trial found chloroquine alone let 27% of Plasmodium vivax patients relapse by day 42; dihydroartemisinin-piperaquine cut that to 2.4%. Paired with primaquine, both drugs did well.
In the TESEO trial, benznidazole for 30 days matched the 60-day standard for clearing the parasite and caused fewer side effects, pointing to a gentler regimen for a neglected disease.
A national registry analysis found the highest burden among 20-to-29-year-olds and a notable rise among girls aged 10 to 19, with rates concentrated in the Sierra region.
A national pharmaceutical database analysis found out-of-pocket purchases accounted for 78-86% of contraceptive use, with emergency contraception priced up to 25 times higher than the insured rate.
Two November burden analyses put diabetes diagnosed before 40 on an upward path to 2050. In the Americas, Central Latin America carried the highest rates and men carried more of the burden than women.
Age, sex, employment and socioeconomic level together explained under 1% of variance in insomnia severity. Perceived stress and generalised anxiety explained close to a third.
The 2025 Lancet Countdown Latin America report tracks 41 indicators across 17 countries. Heat-related deaths are up 103%, and fewer than half the region's governments have finished a vulnerability assessment.